<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Patent ductus arteriosus (PDA) in preterm infants: Clinical features and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Patent ductus arteriosus (PDA) in preterm infants: Clinical features and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Patent ductus arteriosus (PDA) in preterm infants: Clinical features and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph B Philips III, MD, FAAP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph A Garcia-Prats, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David R Fulton, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 14, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H10685779">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the fetus, the ductus arteriosus (DA) is an important vascular connection between the main pulmonary artery and the aorta (
         <a class="graphic graphic_figure graphicRef66765" href="/z/d/graphic/66765.html" rel="external">
          figure 1
         </a>
         ) that diverts blood from the pulmonary artery into the aorta, thereby bypassing the lungs. After birth, the DA undergoes active constriction and eventual obliteration. A patent ductus arteriosus (PDA) (
         <a class="graphic graphic_figure graphicRef65828" href="/z/d/graphic/65828.html" rel="external">
          figure 2
         </a>
         ) occurs when the ductus fails to completely close after delivery. PDA occurs commonly in preterm infants, especially in those with respiratory distress syndrome.
        </p>
        <p>
         The pathophysiology, clinical features, and diagnosis of PDA in preterm infants are reviewed here. The management of PDA in preterm infants, as well as the diagnosis and treatment of PDA in older infants and children, are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/15814.html" rel="external">
          "Patent ductus arteriosus (PDA) in preterm infants: Management and outcome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1421.html" rel="external">
          "Clinical manifestations and diagnosis of patent ductus arteriosus (PDA) in term infants, children, and adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10685787">
         <span class="h1">
          FETAL AND TRANSITIONAL DUCTAL CIRCULATION
         </span>
        </p>
        <p class="headingAnchor" id="H2346124378">
         <span class="h2">
          Circulatory transition at birth
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the fetus, the right ventricle accommodates approximately 65 percent of the total cardiac output. The pulmonary vasculature is constricted, resulting in a high vascular resistance within the pulmonary bed. In contrast, the placenta creates a very low resistance bed arising from the aorta, and systemic vascular resistance is low. As a result, the majority of blood exiting from the right ventricle passes right-to-left across the ductus arteriosus (DA) into the descending aorta and onto the placenta (
         <a class="graphic graphic_figure graphicRef66765" href="/z/d/graphic/66765.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef70458" href="/z/d/graphic/70458.html" rel="external">
          figure 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/4970.html" rel="external">
          "Physiologic transition from intrauterine to extrauterine life", section on 'Fetus'
         </a>
         .)
        </p>
        <p>
         With the onset of respiration after delivery, the lungs expand and the systemic oxygen saturation rises, resulting in pulmonary vasodilatation and a drop in pulmonary vascular resistance. At the same time, systemic resistance rises with placental removal. These factors lead to a sudden reversal of blood flow in the DA from right-to-left to left-to-right shunting with concomitant increase in left ventricular output [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4970.html" rel="external">
          "Physiologic transition from intrauterine to extrauterine life", section on 'Transition at delivery'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10685794">
         <span class="h2">
          Patency of the ductus during fetal development
         </span>
         <span class="headingEndMark">
          —
         </span>
         The fetal ductus arteriosus has a diameter similar to that of the descending aorta (
         <a class="graphic graphic_figure graphicRef66765" href="/z/d/graphic/66765.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid2">
          2
         </a>
         ]. Key factors that maintain ductal patency in the fetus include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low arterial oxygen content
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Endogenous vasodilators, including prostaglandins and nitric oxide
        </p>
        <p>
        </p>
        <p>
         The role of prostaglandins in maintaining ductal patency provides the rationale for the use of inhibitors of prostaglandin synthesis (eg,
         <a class="drug drug_pediatric" data-topicid="13380" href="/z/d/drug information/13380.html" rel="external">
          indomethacin
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">
          ibuprofen
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         [paracetamol]) in the treatment of PDA. (See
         <a class="medical medical_review" href="/z/d/html/15814.html" rel="external">
          "Patent ductus arteriosus (PDA) in preterm infants: Management and outcome", section on 'Pharmacologic therapy'
         </a>
         .)
        </p>
        <p>
         Maternal use of nonsteroidal anti-inflammatory drugs (NSAIDs, eg,
         <a class="drug drug_pediatric" data-topicid="13380" href="/z/d/drug information/13380.html" rel="external">
          indomethacin
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">
          ibuprofen
         </a>
         ) for a prolonged period after 30 weeks gestation also can induce intrauterine ductal constriction [
         <a href="#rid3">
          3,4
         </a>
         ]. Use of NSAIDs during pregnancy is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7998.html" rel="external">
          "Safety of rheumatic disease medication use during pregnancy and lactation", section on 'NSAIDs'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6742.html" rel="external">
          "Inhibition of acute preterm labor", section on 'Cyclooxygenase inhibitors (eg, indomethacin)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10685822">
         <span class="h2">
          Spontaneous ductal closure after birth
         </span>
         <span class="headingEndMark">
          —
         </span>
         At birth, the rise in systemic oxygen tension with the onset of breathing results in active constriction of the ductus, although the mechanisms for this response are not fully understood. In addition, circulating levels of the vasodilator prostaglandin E
         <sub>
          2
         </sub>
         are decreased after delivery because of both reduced production following removal of the placenta and increased pulmonary clearance [
         <a href="#rid5">
          5
         </a>
         ]. The predominance of constricting agents results in ductal constriction. (See
         <a class="medical medical_review" href="/z/d/html/1421.html" rel="external">
          "Clinical manifestations and diagnosis of patent ductus arteriosus (PDA) in term infants, children, and adults", section on 'Ductal constriction'
         </a>
         .)
        </p>
        <p>
         The initial sustained constriction of the ductus is the first step in permanent anatomic closure. Closure begins at the pulmonary end of the ductus and proceeds toward the aortic end [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         Gestational age (GA) has a major impact upon the rate of ductal closure:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Term infants
         </strong>
         – At term, constriction of the ductus results in functional hemodynamic closure usually within the first 12 to 24 hours of birth. Permanent closure is usually completed by two to three weeks of age. (See
         <a class="medical medical_review" href="/z/d/html/1421.html" rel="external">
          "Clinical manifestations and diagnosis of patent ductus arteriosus (PDA) in term infants, children, and adults", section on 'Ductal constriction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preterm infants
         </strong>
         – In preterm infants, ductal constriction and permanent closure are delayed; the risk of PDA increases with decreasing GA. The higher incidence of PDA in preterm infants may be explained by the effect of prematurity on the regulators of ductal tone (eg, oxygen) [
         <a href="#rid7">
          7-10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The natural history of spontaneous ductal closure in extremely preterm infants was described in a study of 214 infants who were managed conservatively [
         <a href="#rid11">
          11
         </a>
         ]. Overall, 91 percent had spontaneous closure at time of last follow-up (median follow-up six months). Spontaneous closure occurred prior to discharge from the neonatal intensive care unit (NICU) in 70 percent of patients at a median of 36 weeks corrected gestational age (CGA). Of the 64 infants who continued to have PDA at time of NICU discharge, 69 percent subsequently had spontaneous closure at a median of 53 weeks CGA. Of the 20 patients who continued to have PDA at last follow-up, all were noted to have small clinically insignificant PDAs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Complete anatomic closure may take up to several months in preterm neonates. Following initial functional constriction, the proliferation and infolding of endothelial cells and migration of undifferentiated smooth muscle cells result in the obliteration of the ductal lumen and conversion to the ligamentum arteriosum [
         <a href="#rid7">
          7,12
         </a>
         ]. These histologic changes depend upon the initial ductal constriction and the resultant hypoxia within the ductal wall. Hypoxia of the inner vessel wall causes loss of cells from the muscle media and production of vascular endothelial growth factor (VEGF). VEGF stimulates endothelial cell proliferation that leads to formation of mounds in the intima that occlude the lumen [
         <a href="#rid8">
          8,13-15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10685844">
         <span class="h2">
          Reopening of the ductus
         </span>
         <span class="headingEndMark">
          —
         </span>
         In term infants, ductal constriction is followed rapidly by histologic changes that generally prevent subsequent reopening. However, in preterm infants, the ductus can reopen after closure (either spontaneous closure or closure induced by medical treatment) [
         <a href="#rid16">
          16,17
         </a>
         ]. Ductal reopening is likely influenced by the same prematurity-related factors that blunt the ductal constriction immediately after birth. In one study of 77 preterm infants who had complete clinical closure of a PDA after
         <a class="drug drug_pediatric" data-topicid="13380" href="/z/d/drug information/13380.html" rel="external">
          indomethacin
         </a>
         treatment, a clinically significant PDA recurred in 23 percent [
         <a href="#rid18">
          18
         </a>
         ]. Ductal reopening occurred more frequently in infants &lt;27 weeks GA compared with more mature infants.
        </p>
        <p class="headingAnchor" id="H10685851">
         <span class="h1">
          CONSEQUENCES OF A PDA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blood flow through a PDA results in a left-to-right shunting from the aorta into the pulmonary arteries. This leads to increased flow through the pulmonary circulation (pulmonary overcirculation) and potentially to hypoperfusion of the systemic circulation (systemic undercirculation). The physiologic consequences of this "ductal steal" depend upon the size of the shunt and the compensatory response of the heart, lungs, and other organs. It should be noted that shunting through the ductus arteriosus is normal during fetal development (although in the fetus, the direction of ductal flow is right-to-left). Ductal shunting can also play an important role during the transition at birth. For example, in newborns with persistent pulmonary hypertension, the ductus relieves excess stress on the right ventricle by shunting blood right-to-left from the pulmonary artery to the aorta. In newborns with ductal-dependent congenital heart disease, the ductus is vital for supporting the circulation. However, in preterm neonates without these conditions, PDAs can have deleterious effects when there is excessive left-to-right shunting.
        </p>
        <p>
         Potential adverse consequences associated with hemodynamically significant PDAs include the effects of pulmonary overcirculation (pulmonary edema, hemorrhage, bronchopulmonary dysplasia [BPD], and pulmonary hypertension [PH]) and the effects of systemic undercirculation (hypotension, necrotizing enterocolitis [NEC], intraventricular hemorrhage [IVH], and acute kidney injury [AKI]).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Effects of pulmonary
         </strong>
         <strong>
          overcirculation
         </strong>
         – In preterm infants, a symptomatic PDA is associated with increased risk of pulmonary edema, pulmonary hemorrhage, BPD, and PH. (See
         <a class="local">
          'Hemodynamically significant PDA'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pulmonary edema
         </strong>
         — Increased pulmonary blood flow from left-to-right shunting across a large PDA can cause pulmonary edema (
         <a class="graphic graphic_diagnosticimage graphicRef71213" href="/z/d/graphic/71213.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pulmonary hemorrhage
         </strong>
         — Larger PDAs with increased pulmonary blood flow and ductal shunting are associated with pulmonary hemorrhage. In a study of 126 infants born before 30 weeks gestation, 12 patients with pulmonary hemorrhage compared with those without pulmonary hemorrhage had greater median PDA diameter (2 versus 0.5 mm) and pulmonary blood flow (326 versus 237 mL/kg per minute) [
         <a href="#rid19">
          19
         </a>
         ]. Ductal diameter measured at five hours of age also was greater in the infants who subsequently developed pulmonary hemorrhage.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          BPD
         </strong>
         — A hemodynamically significant PDA is associated with increased risk of developing BPD [
         <a href="#rid20">
          20-22
         </a>
         ]. In a study of 865 very low birth weight (VLBW) infants (BW &lt;1500 g) who survived to 36 weeks postmenstrual age, patients who were diagnosed with PDA in the first week after birth had a 4.5-fold increased risk of BPD compared with those who did not have PDAs [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The risk of BPD and other long-term pulmonary sequelae may be related to the interplay between the duration of ductal patency and need for mechanical ventilation [
         <a href="#rid23">
          23-25
         </a>
         ]. In a study of 423 infants &lt;27 weeks gestation, an associated between moderate-to-large PDA and risk of BPD was only detected if the PDA had been present for ≥7 days [
         <a href="#rid24">
          24
         </a>
         ]. In another study, moderate-to-large PDAs were associated with increased risk of BPD only among infants requiring ≥10 days of mechanical ventilation [
         <a href="#rid25">
          25
         </a>
         ]. Thus, it appears that prolonged exposure to both a PDA and mechanical ventilation may be required for development of BPD. (See
         <a class="medical medical_review" href="/z/d/html/4987.html" rel="external">
          "Bronchopulmonary dysplasia (BPD): Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pulmonary hypertension
         </strong>
         – PH is an important contributor to morbidity and mortality in preterm infants with BPD. Patients with BPD who have prolonged exposure to moderate-to large PDA are at increased risk for developing PH [
         <a href="#rid26">
          26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/115896.html" rel="external">
          "Pulmonary hypertension associated with bronchopulmonary dysplasia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Effects of systemic
         </strong>
         <strong>
          undercirculation
         </strong>
         – Although preterm infants with a PDA typically have compensatory increased cardiac output, the postductal blood flow may be reduced because if there is a large left-to-right shunt. Moderate and large ductal steals in infants with PDA result in reduced oxygen delivery and perfusion to vital organs and may contribute to an increased risk of IVH and NEC.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Hypotension
         </strong>
         — Moderate or large PDAs can be associated with clinically significant hypotension requiring vasoactive therapy [
         <a href="#rid27">
          27-29
         </a>
         ]. In some cases, hypotension can persist even after surgical ligation of the PDA and it may be refractory to vasopressor therapy. This may be due to low cortisol levels, impaired ventricular function, and/or abnormal vascular tone [
         <a href="#rid30">
          30,31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126605.html" rel="external">
          "Neonatal shock: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Intraventricular hemorrhage
         </strong>
         — Moderate or large left-to-right shunts appear to be associated with increased risk of IVH, most likely due to the hemodynamic instability that can occur neonates with large PDAs [
         <a href="#rid32">
          32
         </a>
         ]. Infants with significant PDAs also have reduced cerebral blood flow and oxygenation, but data are lacking demonstrating an association of these findings with IVH [
         <a href="#rid33">
          33,34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5051.html" rel="external">
          "Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis", section on 'Risk factors other than GA'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Necrotizing enterocolitis
         </strong>
         — It is thought that decreased blood flow to the abdominal aorta from ductal steal through large PDAs may contribute to increased risk of NEC in preterm neonates. However, data are lacking to conclusively demonstrate that the circulatory instability associated with PDA contributes to risk of NEC. (See
         <a class="medical medical_review" href="/z/d/html/4991.html" rel="external">
          "Neonatal necrotizing enterocolitis: Pathology and pathogenesis", section on 'Circulatory instability'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute kidney injury
         </strong>
         – Neonates with large PDAs are at increased risk of AKI [
         <a href="#rid35">
          35,36
         </a>
         ]. In a secondary analysis of the AWAKEN cohort study that included 526 VLBW infants, the incidence of AKI was nearly two-fold higher in infants with versus without PDA (55 versus 24 percent, respectively) [
         <a href="#rid36">
          36
         </a>
         ]. In this study, PDA management strategy (conservative management versus pharmacologic treatment versus surgical or transcatheter intervention) did not appear to influence the likelihood of AKI. Other studies have demonstrated that medical therapy with nonselective cyclooxygenase (COX) inhibitors, particularly
         <a class="drug drug_pediatric" data-topicid="13380" href="/z/d/drug information/13380.html" rel="external">
          indomethacin
         </a>
         , is associated with increased risk of AKI. (See
         <a class="medical medical_review" href="/z/d/html/15814.html" rel="external">
          "Patent ductus arteriosus (PDA) in preterm infants: Management and outcome", section on 'Adverse effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3529204169">
         <span class="h1">
          RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of PDA increases with decreasing gestational age (GA) and birth weight (BW), and chromosomal abnormalities [
         <a href="#rid37">
          37-41
         </a>
         ]. In very low birth weight (VLBW) infants (BW &lt;1500 g), the incidence of PDA is approximately 30 percent [
         <a href="#rid42">
          42
         </a>
         ]. For healthy infants greater than 30 weeks gestation, the ductus typically closes by the fourth day of life [
         <a href="#rid43">
          43
         </a>
         ]. However, two-thirds of ill infants less than 30 weeks gestation will have a persistent PDA through the fourth day of life and closure is especially delayed for moderate to large PDAs [
         <a href="#rid16">
          16,44
         </a>
         ]. Closure is also less likely to occur in infants who have neonatal respiratory distress syndrome, who did not receive antenatal corticosteroids, who have evidence of metabolic acidosis or with exposure to chorioamnionitis [
         <a href="#rid16">
          16,45,46
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10685894">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical features of PDA are dependent on the magnitude of the shunt. Those with hemodynamically significant PDAs will exhibit findings of pulmonary overcirculation and left heart overload. These patients typically develop signs during the first two to three days after birth. Clinical findings may develop earlier in infants treated with surfactant because the reduction in pulmonary vascular resistance (PVR) associated with improved lung function results in increased left-to-right shunting [
         <a href="#rid47">
          47-49
         </a>
         ]. Heart failure may rarely develop later in the first week. In a few patients, asymptomatic PDA can persist with closure occurring after 10 days of age [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1097523469">
         <span class="h2">
          Heart murmur
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with moderate to large PDAs, cardiac auscultation detects a murmur often heard over the entire precordium, but best heard in the left infraclavicular region and upper left sternal border. At delivery with high PVR, the murmur initially may be heard only in systole because aortic pressure is greater than pulmonary pressure only in systole and not in diastole. As PVR and pulmonary artery pressure (PAP) fall, aortic pressure is higher than PAP during both systole and diastole, producing continuous flow through the ductus and the continuous (machinery) murmur typically associated with a PDA (
         <a class="graphic graphic_movie graphicRef104792" href="/z/d/graphic/104792.html" rel="external">
          movie 1
         </a>
         ).
        </p>
        <p>
         For patients with a small PDA, a murmur may not be detected. Occasionally, even a larger PDA is clinically "silent" with absence of a murmur, especially in the first three days after birth [
         <a href="#rid50">
          50,51
         </a>
         ]. In these cases, if there is a hemodynamically significant PDA, there may be signs associated with pulmonary overcirculation and left ventricular overload depending on the degree of PVR.
        </p>
        <p class="headingAnchor" id="H3752057038">
         <span class="h2">
          Findings associated with hemodynamically significant PDA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical findings associated with a hemodynamically significant PDA include (
         <a class="graphic graphic_table graphicRef141521" href="/z/d/graphic/141521.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Signs of increased pulmonary circulation, including tachypnea, apnea, and/or increased requirements for respiratory support including mechanical ventilation. Chest radiography typically demonstrates increased pulmonary vascular markings and/or edema (
         <a class="graphic graphic_diagnosticimage graphicRef71213" href="/z/d/graphic/71213.html" rel="external">
          image 1
         </a>
         ). (See
         <a class="local">
          'Radiographic and laboratory findings'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Signs of left ventricular overload include prominent left ventricular impulse and cardiomegaly on chest radiograph (
         <a class="graphic graphic_diagnosticimage graphicRef71213" href="/z/d/graphic/71213.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systemic circulatory findings include bounding pulses and a widened pulse pressure (&gt;25 mmHg difference between diastolic and systolic blood pressure [BP] or diastolic BP &lt;50 percent of the systolic BP). Diastolic BP is typically low in patients with hemodynamically significant PDAs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other clinical findings due to poor systemic perfusion include acidosis, oliguria, and abdominal distension.
        </p>
        <p>
        </p>
        <p>
         However, no single finding is specific for a PDA. Similar findings can occur with other cardiac lesions. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2508167316">
         <span class="h2">
          Associated complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complications of prematurity that occur more commonly among infants with a hemodynamically significant PDA include (see
         <a class="local">
          'Consequences of a PDA'
         </a>
         above):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pulmonary edema
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bronchopulmonary dysplasia (BPD) [
         <a href="#rid52">
          52
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Necrotizing enterocolitis (NEC) [
         <a href="#rid53">
          53
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Heart failure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intraventricular hemorrhage (IVH) [
         <a href="#rid54">
          54
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prolonged need for ventilator and/or oxygen support
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute kidney injury [
         <a href="#rid35">
          35,36
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3841176536">
         <span class="h2">
          Radiographic and laboratory findings
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chest radiograph
         </strong>
         – In patients with large PDAs, the chest radiograph typically shows cardiac enlargement and increased pulmonary vascular markings (
         <a class="graphic graphic_diagnosticimage graphicRef71213" href="/z/d/graphic/71213.html" rel="external">
          image 1
         </a>
         ). However, these findings are nonspecific and can be seen in other causes of neonatal heart failure (eg, congenital heart disease [CHD]).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP)
         </strong>
         – Patients with large PDAs often have elevated BNP or NT-proBNP levels indicating increased filling pressures in the heart [
         <a href="#rid55">
          55-58
         </a>
         ]. However, clear reference ranges and cut-off values have not been established in the preterm neonatal population and the diagnostic accuracy of these tests vary depending on the assay used and the population studied [
         <a href="#rid59">
          59
         </a>
         ]. Elevated BNP or NT-proBNP is not a specific finding of PDA since it can also be seen in neonates with CHD or severe respiratory disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The role of monitoring BNP or NT-proBNP in neonates with large PDAs (eg, to assess for spontaneous closure and/or determine the need for treatment) is unclear and requires further study. In our center, we do not use BNP or NT-proBNP levels for this purpose.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Electrocardiogram (ECG)
         </strong>
         – The ECG is not helpful in the diagnosis of PDA in preterm infants.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10685901">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of PDA is usually suspected by its characteristic clinical findings (murmur, widened pulse pressure, signs of pulmonary congestion) (
         <a class="graphic graphic_table graphicRef141521" href="/z/d/graphic/141521.html" rel="external">
          table 1
         </a>
         ) and is confirmed by echocardiography.
        </p>
        <p class="headingAnchor" id="H3931217743">
         <span class="h2">
          Echocardiogram
         </span>
         <span class="headingEndMark">
          —
         </span>
         Echocardiogram is performed to confirm the presence of a clinically significant PDA. The combination of two-dimensional echocardiographic imaging and Doppler color flow mapping is both sensitive and specific for the identification of PDA (
         <a class="graphic graphic_movie graphicRef95136" href="/z/d/graphic/95136.html" rel="external">
          movie 2
         </a>
         and
         <a class="graphic graphic_movie graphicRef95135" href="/z/d/graphic/95135.html" rel="external">
          movie 3
         </a>
         ) [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
         We do not routinely perform echocardiography in preterm infants without a murmur or other clinical findings suggestive of PDA unless there is an unexplained deterioration in respiratory status, which may raise clinical suspicion for a "silent" PDA. (See
         <a class="local">
          'Clinical features'
         </a>
         above and
         <a class="local">
          'No role for routine screening'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H10685908">
         <span class="h2">
          Hemodynamically significant PDA
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is important to distinguish between a hemodynamically significant PDA versus a trivial or mild (small) PDA. PDAs that are not hemodynamically significant do not require intervention. The need for intervention in patients with hemodynamically significant PDAs depends on the severity and persistence of the findings, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/15814.html" rel="external">
          "Patent ductus arteriosus (PDA) in preterm infants: Management and outcome", section on 'Our approach'
         </a>
         .)
        </p>
        <p>
         In our practice, we define "hemodynamically significant" using both clinical findings and echocardiographic measurements [
         <a href="#rid41">
          41,61
         </a>
         ]. The assessment is based upon multiple findings rather than a single isolated finding.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical findings
         </strong>
         that indicate a clinically significant PDA include (
         <a class="graphic graphic_table graphicRef141521" href="/z/d/graphic/141521.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Findings associated with hemodynamically significant PDA'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Need for substantial respiratory support (mean airway pressure ≥8 cm H2O and/or fraction of inspired oxygen [FiO2] &gt;0.4)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Evidence of hypoperfusion (oliguria, acidosis, need for vasoactive medication to treat hypotension) that are not otherwise explained
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Physical findings of wide pulse pressure (&gt;25 mmHg difference between diastolic and systolic blood pressure [BP] or diastolic BP &lt;50 percent of the systolic BP) or pulmonary rales
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiomegaly on chest radiograph (
         <a class="graphic graphic_diagnosticimage graphicRef71213" href="/z/d/graphic/71213.html" rel="external">
          image 1
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Echocardiographic findings
         </strong>
         that indicate a hemodynamically significant include (
         <a class="graphic graphic_table graphicRef141537" href="/z/d/graphic/141537.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid41">
          41,62,63
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         PDA diameter &gt;1.5 mm [
         <a href="#rid41">
          41,62,64-66
         </a>
         ]. However, the PDA diameter may need to be adjusted for size of the patient especially in the smallest infants. This can be done by correcting the measurement for the infant's body surface area or in relation with the diameter of left pulmonary artery (LPA) [
         <a href="#rid62">
          62,63
         </a>
         ]. A PDA:LPA diameter ratio of ≥1 indicates a large PDA and a ratio of ≥0.5 to &lt;1 indicates a moderate PDA [
         <a href="#rid67">
          67,68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diastolic flow reversal in the abdominal aorta. This finding is a highly sensitive marker of a clinically significant PDA [
         <a href="#rid62">
          62,63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Flow velocity ≤2.5 m/sec across the PDA or mean pressure gradient of ≤8 mmHg across the PDA. This finding indicates unrestricted flow consistent with a large PDA.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Left atrial or left ventricular chamber enlargement
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3279824943">
         <span class="h1">
          NO ROLE FOR ROUTINE SCREENING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Universal screening for PDA in extremely preterm (EPT) infants (gestational age [GA] &lt;28 weeks) has been proposed as a strategy to reduce morbidity and mortality associated with PDA in this population. However, the evidence remains inconclusive. As a result, we suggest against routine screening. We perform echocardiography selectively only if there are clinical signs of a hemodynamically significant PDA. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
         The impact of universal screening was investigated in a study of 1513 EPT infants from the EPIPAGE 2 cohort, a prospective population-based study conducted in France [
         <a href="#rid69">
          69
         </a>
         ]. Screening echocardiogram was performed in 56 percent of patients (n = 847), whereas 44 percent (n = 666) did not undergo screening. In propensity score analysis, PDA screening was associated with lower in-hospital mortality (14 versus 18 percent; odds ratio [OR] 0.73, 95% CI 0.54-0.98) and a lower incidence of pulmonary hemorrhage (5.6 versus 8.9 percent; OR 0.60, 95% CI 0.38-0.95). The higher mortality in the non-screened group was primarily observed in untreated infants; however, it is unclear how many of these patients had PDAs. Rates of NEC, severe BPD, and severe cerebral injury were similar in both groups.
        </p>
        <p>
         A follow-up study reported neurodevelopmental outcomes at 5.5 years in 71 percent of surviving infants from the original propensity score matched cohort of EPIPAGE 2 [
         <a href="#rid70">
          70
         </a>
         ]. Rates of moderate to severe neurodevelopmental impairment (NDI) were similar in screened and non-screened infants (24 versus 28 percent, respectively). On standardized testing, children in the screened group scored higher on two domains of intelligence, but full-scale intelligence quotients were similar in both groups. There were few deaths in either group after discharge from the initial neonatal hospitalization. Overall, more infants in the screened group survived to age 5.5 years without moderate to severe NDI (65 versus 59 percent), though this finding had borderline statistical significance (OR 1.3, 95% CI 1.0-1.68).
        </p>
        <p>
         The findings of EPIPAGE 2 are promising; however, given the observational nature of these data, it is possible that some of the observed differences between screened and non-screened infants in these studies may be explained by selection bias. The notion that early diagnosis and treatment of PDA improve outcomes is contradicted by multiple randomized trials comparing early treatment with expectant management of PDA. These trials have generally demonstrated that while early treatment results in earlier closure of the PDA, other clinical outcomes (mortality, bronchopulmonary dysplasia [BPD], necrotizing enterocolitis [NEC], NDI) are generally similar between the two approaches [
         <a href="#rid71">
          71
         </a>
         ]. These data are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/15814.html" rel="external">
          "Patent ductus arteriosus (PDA) in preterm infants: Management and outcome", section on 'Comparison of approaches'
         </a>
         .)
        </p>
        <p>
         The findings of the EPIPAGE 2 study should be confirmed in randomized trials before universal screening is adopted into routine clinical practice. In particular, the cost-benefit of universal versus selective screening remains uncertain.
        </p>
        <p class="headingAnchor" id="H3134201024">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other diagnoses associated with continuous murmurs include systemic arteriovenous malformations, fistula, and aortic-pulmonary window. These are far less common than PDA. Occasionally, combined aortic stenosis and regurgitation or combined pulmonic stenosis and regurgitation will have murmurs through diastole and systole described as a "to-and-fro" murmur rather than one with a continuous quality as seen in those with a PDA. PDA can be distinguished from these conditions with echocardiography. (See
         <a class="medical medical_review" href="/z/d/html/1421.html" rel="external">
          "Clinical manifestations and diagnosis of patent ductus arteriosus (PDA) in term infants, children, and adults", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H728294868">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition and physiology
         </strong>
         – The ductus arteriosus (DA) is a fetal vascular connection between the main pulmonary artery and the aorta (
         <a class="graphic graphic_figure graphicRef66765" href="/z/d/graphic/66765.html" rel="external">
          figure 1
         </a>
         ) that normally closes soon after birth. A patent ductus arteriosus (PDA) (
         <a class="graphic graphic_figure graphicRef65828" href="/z/d/graphic/65828.html" rel="external">
          figure 2
         </a>
         )occurs when the ductus fails to completely close after delivery. (See
         <a class="local">
          'Fetal and transitional ductal circulation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In patients with a PDA, the left-to-right shunting of blood results in an excessive blood flow through the pulmonary circulation and potential hypoperfusion of the systemic circulation. The physiologic consequences of this "ductal steal" depend upon the size of the shunt and the response of the heart, lungs, and other organs to the shunt.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – Ductal closure is delayed in preterm infants and the risk of PDA is inversely proportional to gestational age (GA). Closure is also less likely to occur in infants who have neonatal respiratory distress syndrome and who did not receive antenatal corticosteroids. (See
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – The following clinical features are seen in most preterm infants with a hemodynamically significant PDA (
         <a class="graphic graphic_table graphicRef141521" href="/z/d/graphic/141521.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Findings associated with hemodynamically significant PDA'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Heart murmur – In most infants with a moderate to large PDA shunt, cardiac auscultation demonstrates a heart murmur heard over the entire precordium, but best heard in the left infraclavicular region and upper left sternal border. Immediately after delivery when PVR is high, the murmur initially may be heard only in systole. As PVR falls, the murmur can be heard in systole and diastole, producing the characteristic continuous PDA murmur (
         <a class="graphic graphic_movie graphicRef104792" href="/z/d/graphic/104792.html" rel="external">
          movie 1
         </a>
         ). (See
         <a class="local">
          'Heart murmur'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiovascular findings indicative of left ventricular overload and diastolic runoff include prominent left ventricular impulse, bounding pulses, widened pulse pressure, systemic hypotension, and cardiomegaly on chest radiograph (
         <a class="graphic graphic_diagnosticimage graphicRef71213" href="/z/d/graphic/71213.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Findings of pulmonary overcirculation include tachypnea, apnea, need for substantial respiratory support, and evidence of pulmonary edema on chest radiograph (
         <a class="graphic graphic_diagnosticimage graphicRef71213" href="/z/d/graphic/71213.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other findings may include oliguria and metabolic acidosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of PDA is usually suggested based upon the characteristic clinical findings (eg, heart murmur, widened pulse pressure, signs of pulmonary congestion (
         <a class="graphic graphic_table graphicRef141521" href="/z/d/graphic/141521.html" rel="external">
          table 1
         </a>
         )) and confirmed by echocardiography (
         <a class="graphic graphic_movie graphicRef95136" href="/z/d/graphic/95136.html" rel="external">
          movie 2
         </a>
         and
         <a class="graphic graphic_movie graphicRef95135" href="/z/d/graphic/95135.html" rel="external">
          movie 3
         </a>
         ). (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Consequences and complications of PDA
         </strong>
         – Infants with hemodynamically significant PDA have clinical and echocardiographic findings that indicate significant left-to-right shunting, including evidence of pulmonary overcirculation (pulmonary edema, high respiratory support requirements) and evidence of systemic undercirculation (eg, oliguria, metabolic acidosis). Infants with these findings are at risk for adverse consequences of PDA including pulmonary hemorrhage, bronchopulmonary dysplasia, pulmonary hypertension, necrotizing enterocolitis, intraventricular hemorrhage, and acute kidney injury. (See
         <a class="local">
          'Consequences of a PDA'
         </a>
         above and
         <a class="local">
          'Associated complications'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Jain A, El-Khuffash AF, Kuipers BCW, et al. Left Ventricular Function in Healthy Term Neonates During the Transitional Period. J Pediatr 2017; 182:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith GC. The pharmacology of the ductus arteriosus. Pharmacol Rev 1998; 50:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moise KJ Jr. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol 1993; 168:1350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vermillion ST, Scardo JA, Lashus AG, Wiles HB. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997; 177:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Mauray F, Roman C, et al. Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs. J Pediatr 1980; 97:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gittenberger-de Groot AC, Strengers JL, Mentink M, et al. Histologic studies on normal and persistent ductus arteriosus in the dog. J Am Coll Cardiol 1985; 6:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Waleh N, Black SM, et al. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum. Pediatr Res 1998; 43:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Chan CY, Mauray F, et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res 1999; 45:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI. Ductus arteriosus: current theories of prenatal and postnatal regulation. Semin Perinatol 1987; 11:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Mauray F, Roman C, et al. Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2. J Pediatr 1983; 102:907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Carvalho Nunes G, Wutthigate P, Simoneau J, et al. Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes. J Perinatol 2022; 42:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gittenberger-de Groot AC. Persistent ductus arteriosus: most probably a primary congenital malformation. Br Heart J 1977; 39:610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandner P, Wolf K, Bergmaier U, et al. Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro. Kidney Int 1997; 51:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995; 95:1798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waleh N, Seidner S, McCurnin D, et al. Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation. Pediatr Res 2011; 70:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koch J, Hensley G, Roy L, et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quinn D, Cooper B, Clyman RI. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy. Pediatrics 2002; 110:e10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss H, Cooper B, Brook M, et al. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr 1995; 127:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000; 137:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Todd DA, Jana A, John E. Chronic oxygen dependency in infants born at 24-32 weeks' gestation: the role of antenatal and neonatal factors. J Paediatr Child Health 1997; 33:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagan R, Minutillo C, French N, et al. Neonatal chronic lung disease, oxygen dependency, and a family history of asthma. Pediatr Pulmonol 1995; 20:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marshall DD, Kotelchuck M, Young TE, et al. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999; 104:1345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saldeño YP, Favareto V, Mirpuri J. Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants. J Perinatol 2012; 32:953.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Hills NK, Liebowitz M, Johng S. Relationship between Duration of Infant Exposure to a Moderate-to-Large Patent Ductus Arteriosus Shunt and the Risk of Developing Bronchopulmonary Dysplasia or Death Before 36 Weeks. Am J Perinatol 2020; 37:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Hills NK, Cambonie G, et al. Patent ductus arteriosus, tracheal ventilation, and the risk of bronchopulmonary dysplasia. Pediatr Res 2022; 91:652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gentle SJ, Travers CP, Clark M, et al. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension. Am J Respir Crit Care Med 2023; 207:921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liebowitz M, Koo J, Wickremasinghe A, et al. Effects of Prophylactic Indomethacin on Vasopressor-Dependent Hypotension in Extremely Preterm Infants. J Pediatr 2017; 182:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouissou A, Rakza T, Klosowski S, et al. Hypotension in preterm infants with significant patent ductus arteriosus: effects of dopamine. J Pediatr 2008; 153:790.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giliberti P, De Leonibus C, Giordano L, Giliberti P. The physiopathology of the patent ductus arteriosus. J Matern Fetal Neonatal Med 2009; 22 Suppl 3:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noori S, McNamara P, Jain A, et al. Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation. J Perinatol 2015; 35:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Wickremasinghe A, Merritt TA, et al. Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones. J Pediatr 2014; 164:1449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000; 82:F188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin CG, Snider AR, Katz SM, et al. Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosus. J Pediatr 1982; 101:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemmers PM, Toet MC, van Bel F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics 2008; 121:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Majed B, Bateman DA, Uy N, Lin F. Patent ductus arteriosus is associated with acute kidney injury in the preterm infant. Pediatr Nephrol 2019; 34:1129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guillet R, Selewski DT, Griffin R, et al. Relationship of patent ductus arteriosus management with neonatal AKI. J Perinatol 2021; 41:1441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellison RC, Peckham GJ, Lang P, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983; 71:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furzan JA, Reisch J, Tyson JE, et al. Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants. Early Hum Dev 1985; 12:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mouzinho AI, Rosenfeld CR, Risser R. Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989. Early Hum Dev 1991; 27:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reller MD, Lorenz JM, Kotagal UR, et al. Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance. Pediatr Cardiol 1985; 6:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamrick SEG, Sallmon H, Rose AT, et al. Patent Ductus Arteriosus of the Preterm Infant. Pediatrics 2020; 146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001; 107:E1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reller MD, Rice MJ, McDonald RW. Review of studies evaluating ductal patency in the premature infant. J Pediatr 1993; 122:S59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dudell GG, Gersony WM. Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 1984; 104:915.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kindler A, Seipolt B, Heilmann A, et al. Development of a Diagnostic Clinical Score for Hemodynamically Significant Patent Ductus Arteriosus. Front Pediatr 2017; 5:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green CA, Westreich D, Laughon MM, et al. Association of chorioamnionitis and patent ductus arteriosus in a national U.S. cohort. J Perinatol 2021; 41:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seppänen M, Kääpä P, Kero P. Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome. Am J Perinatol 1994; 11:382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Jobe A, Heymann M, et al. Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr 1982; 100:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kääpä P, Seppänen M, Kero P, Saraste M. Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome. J Pediatr 1993; 123:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammerman C, Strates E, Valaitis S. The silent ductus: its precursors and its aftermath. Pediatr Cardiol 1986; 7:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health 1994; 30:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman R, Cassady G, Kirklin JK, et al. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 2009; 154:873.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cassady G, Crouse DT, Kirklin JW, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989; 320:1511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344:1966.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans N. Diagnosis of the preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound? Semin Perinatol 2012; 36:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan SS, Sithisarn T, Bada HS, et al. Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus. J Perinatol 2017; 37:1319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodriguez-Blanco S, Oulego-Erroz I, Gautreaux-Minaya S, et al. Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants. J Perinatol 2018; 38:881.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asrani P, Aly AM, Jiwani AK, et al. High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus. J Perinatol 2018; 38:1483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kulkarni M, Gokulakrishnan G, Price J, et al. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review. Pediatrics 2015; 135:e510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huhta JC, Cohen M, Gutgesell HP. Patency of the ductus arteriosus in normal neonates: two-dimensional echocardiography versus Doppler assessment. J Am Coll Cardiol 1984; 4:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007; 92:F498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman RI, Liebowitz M, Kaempf J, et al. PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J Pediatr 2019; 205:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Freitas Martins F, Ibarra Rios D, F Resende MH, et al. Relationship of Patent Ductus Arteriosus Size to Echocardiographic Markers of Shunt Volume. J Pediatr 2018; 202:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010; 125:1020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harling S, Hansen-Pupp I, Baigi A, Pesonen E. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention. Acta Paediatr 2011; 100:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995; 127:774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramos FG, Rosenfeld CR, Roy L, et al. Echocardiographic predictors of symptomatic patent ductus arteriosus in extremely-low-birth-weight preterm neonates. J Perinatol 2010; 30:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thankavel PP, Rosenfeld CR, Christie L, Ramaciotti C. Early echocardiographic prediction of ductal closure in neonates ≤ 30 weeks gestation. J Perinatol 2013; 33:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rozé JC, Cambonie G, Marchand-Martin L, et al. Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants. JAMA 2015; 313:2441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cambonie G, Rozé JC, Marchand-Martin L, et al. Neurodevelopment at 5 Years of Age According to Early Screening for Patent Ductus Arteriosus in Extremely Preterm Infants. JAMA 2022; 328:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitra S, Scrivens A, von Kursell AM, Disher T. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. Cochrane Database Syst Rev 2020; 12:CD013278.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5057 Version 42.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27908646" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Left Ventricular Function in Healthy Term Neonates During the Transitional Period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9549757" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The pharmacology of the ductus arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8498410" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9290437" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6902770" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4019926" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Histologic studies on normal and persistent ductus arteriosus in the dog.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9585010" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9890604" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3551085" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Ductus arteriosus: current theories of prenatal and postnatal regulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6854456" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34815521" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/884011" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Persistent ductus arteriosus: most probably a primary congenital malformation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9027720" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7706486" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21691249" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16585305" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12093991" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7658282" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10891824" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9401883" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Chronic oxygen dependency in infants born at 24-32 weeks' gestation: the role of antenatal and neonatal factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8903898" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Neonatal chronic lung disease, oxygen dependency, and a family history of asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10585987" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22460543" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31600791" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Relationship between Duration of Infant Exposure to a Moderate-to-Large Patent Ductus Arteriosus Shunt and the Risk of Developing Bronchopulmonary Dysplasia or Death Before 36 Weeks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33790415" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Patent ductus arteriosus, tracheal ventilation, and the risk of bronchopulmonary dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36378949" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27915200" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Effects of Prophylactic Indomethacin on Vasopressor-Dependent Hypotension in Extremely Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18675433" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Hypotension in preterm infants with significant patent ductus arteriosus: effects of dopamine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19718587" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The physiopathology of the patent ductus arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25118721" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24636853" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10794784" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Low superior vena cava flow and intraventricular haemorrhage in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7119964" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18166568" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30706125" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Patent ductus arteriosus is associated with acute kidney injury in the preterm infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33875795" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Relationship of patent ductus arteriosus management with neonatal AKI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6338474" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Evaluation of the preterm infant for patent ductus arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4064996" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1802665" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4011463" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33093140" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Patent Ductus Arteriosus of the Preterm Infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11134465" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8501549" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Review of studies evaluating ductal patency in the premature infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6726527" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Patent ductus arteriosus in neonates with severe respiratory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29312911" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Development of a Diagnostic Clinical Score for Hemodynamically Significant Patent Ductus Arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33093626" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Association of chorioamnionitis and patent ductus arteriosus in a national U.S. cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7857426" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6948942" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Increased shunt through the patent ductus arteriosus after surfactant replacement therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8320604" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3468491" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The silent ductus: its precursors and its aftermath.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7833075" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19324366" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2498657" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11430325" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22414882" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Diagnosis of the preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28906496" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29785059" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30171214" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25601976" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6470337" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Patency of the ductus arteriosus in normal neonates: two-dimensional echocardiography versus Doppler assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17951552" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Patent ductus arteriosus: lack of evidence for common treatments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30340932" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30115452" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Relationship of Patent Ductus Arteriosus Size to Echocardiographic Markers of Shunt Volume.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20421261" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Patent ductus arteriosus of the preterm infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20874741" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7472835" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20182434" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Echocardiographic predictors of symptomatic patent ductus arteriosus in extremely-low-birth-weight preterm neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22499084" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Early echocardiographic prediction of ductal closure in neonates≤30 weeks gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26103028" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35788802" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Neurodevelopment at 5 Years of Age According to Early Screening for Patent Ductus Arteriosus in Extremely Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33301630" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
